| Drug Type Autologous CAR-T | 
| Synonyms- | 
| Target | 
| Action antagonists | 
| Mechanism CXCR5 antagonists(C-X-C motif chemokine receptor 5 antagonists), EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), Gene transference(Gene transference) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Non-Small Cell Lung Cancer | Phase 1 | China  | - | |
| Non-Small Cell Lung Cancer | Phase 1 | China  | - | 





